15 Best High-Yield Dividend Stocks for 2025 and Beyond
Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 13,458,826 | $820,853,797 | +2% | 2.87% |
| 2. | Skylands Capital Charles Paquelet | 142,450 | $8,688,026 | -13% | 1.25% |
| 3. | Impax Asset Management Ian Simm | 131,431 | $8,015,977 | -12% | 0.05% |
| 4. | Leucadia National Ian Cumming And Joseph Steinberg | 50,151 | $3,058,710 | -80% | 0.03% |
| 5. | Factorial Partners Mark Kleiman | 36,500 | $2,226,135 | 1.37% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.58 | 4,250 | Officer | 83,513 | 2025-04-25 | Filing | |
| $55.05 | 2,000 | Officer, Director | 104,626 | 2025-02-20 | Filing | |
| $54.84 | 1,823 | Officer | 63,932 | 2025-02-14 | Filing | |
| $54.68 | 1,830 | Officer | 62,109 | 2024-11-01 | Filing | |
| $49.78 | 2,000 | Officer | 82,672 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.62 | 700 | Officer | 11,760 | 2024-11-04 | Filing | |
| $61.25 | 17,986 | Officer | 27,868 | 2023-08-24 | Filing | |
| $61.14 | 732 | Officer | 6,584 | 2023-08-03 | Filing | |
| $67.06 | 50,385 | Officer | 47,751 | 2023-05-03 | Filing | |
| $74.65 | 240,000 | Officer, Director | 236,104 | 2023-02-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 191,403,004 | $11,673,669,214 | 0.21% | |
| 2. | 161,366,354 | $9,841,733,950 | 0.21% | |
| 3. | 60,606,905 | $3,696,415,151 | 0.69% | |
| 4. | 26,865,073 | $1,638,500,764 | 0.32% | |
| 5. | 22,970,633 | $1,400,978,905 | 1.16% |
News See All
Did Jim Cramer Hit or Miss On These 13 Stock Predictions?
“Alright, look, lately, we can’t go a day without hearing some widespread misperceptions about stock ownership. I gotta tell you, I think it’s infuriating.
10 Jim Cramer Stocks to Watch Amid Trump Tariff Wars
Jim Cramer in a latest program on CNBC talked about the latest signs of de-escalation in trade wars between the US and China and told investors that even bear market rallies could be a positive sign.
10 Best Long-Term Dividend Stocks to Buy According to Billionaires
Dividend stocks are increasingly popular with both every day and billionaire investors.
10 Stocks to Watch as Trade Wars Begin
Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC that the market isn’t done going down and urged investors not to buy every dip and wait for real opportunities...
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Bristol-Myers Squibb Company First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode.
30 Growing Dividend Stocks with Low PE Ratios
Value stocks are enjoying a rare period of strength amid this year’s broader market downturn.
10 Best Stocks That Will Always Grow
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
10 Dirt Cheap Stocks To Invest In Now
The stock market has been experiencing volatility and has quickly shifted from the post-election highs to being priced for recession.
10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.